Shams Tabrez Selected Research

sugiol

1/2022

Sugiol Suppresses the Proliferation of Human U87 Glioma Cells via Induction of Apoptosis and Cell Cycle Arrest.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shams Tabrez Research Topics

Disease

29	Neoplasms (Cancer) 11/2022 - 01/2012
10	Inflammation (Inflammations) 03/2022 - 01/2013
10	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2013
9	Leishmaniasis 12/2021 - 01/2018
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 06/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 06/2015
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2020 - 01/2018
4	Breast Neoplasms (Breast Cancer) 05/2019 - 12/2013
4	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2015
4	Atherosclerosis 01/2019 - 12/2013
4	Type 2 Diabetes Mellitus (MODY) 08/2014 - 01/2014
3	Infections 01/2018 - 01/2015
3	Cataract (Cataracts) 11/2016 - 12/2013
3	Parkinson Disease (Parkinson's Disease) 01/2015 - 06/2012
2	Dementia (Dementias) 12/2021 - 04/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 01/2015
2	Heart Failure 01/2019 - 01/2017
2	Neuroblastoma 12/2018 - 05/2015
2	Myocardial Infarction 07/2017 - 12/2016
2	Hyperglycemia 09/2015 - 01/2015
2	Hemolysis 01/2015 - 01/2015
2	Arthritis (Polyarthritis) 01/2015 - 12/2013
1	Glioma (Gliomas) 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 10/2021
1	COVID-19 03/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Genomic Instability 05/2019
1	Thrombosis (Thrombus) 01/2019
1	Insulin Resistance 01/2019
1	Reperfusion Injury 01/2019
1	Stroke (Strokes) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Pulmonary Hypertension 01/2019

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 11/2022 - 01/2013
11	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2014
5	Biological ProductsIBA 11/2022 - 01/2015
4	SterolsIBA 12/2021 - 03/2021
4	FlavonoidsIBA 11/2021 - 08/2020
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 08/2014
3	LigandsIBA 01/2021 - 04/2014
3	PolyphenolsIBA 01/2020 - 01/2013
3	Galectins (Galectin)IBA 08/2018 - 01/2015
3	Amyloid (Amyloid Fibrils)IBA 01/2018 - 04/2014
3	CytokinesIBA 01/2017 - 01/2015
3	AntibodiesIBA 03/2016 - 08/2014
2	NeopterinIBA 03/2022 - 06/2015
2	Interleukin-6 (Interleukin 6)IBA 03/2022 - 09/2017
2	DiterpenesIBA 01/2022 - 01/2018
2	MethyltransferasesIBA 12/2021 - 05/2021
2	Rutin (Rutoside)IBA 03/2021 - 12/2018
2	QuercetinIBA 02/2021 - 01/2020
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2015
2	EnzymesIBA 01/2019 - 03/2014
2	Cholinesterases (Cholinesterase)IBA 01/2019 - 01/2018
2	AntioxidantsIBA 01/2018 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2015
2	tau Proteins (tau Protein)IBA 01/2018 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2015
2	Interleukin-18 (Interleukin 18)IBA 01/2017 - 03/2015
2	C-Reactive ProteinIBA 12/2016 - 01/2015
2	Crystallins (Crystallin)IBA 11/2016 - 01/2016
2	Insulin (Novolin)FDA Link 05/2015 - 03/2014
2	Uric Acid (Urate)IBA 03/2015 - 01/2015
2	CarbohydratesIBA 01/2015 - 01/2015
2	Sulfhydryl Compounds (Thiols)IBA 01/2015 - 10/2013
2	LectinsIBA 01/2015 - 01/2015
2	Advanced Glycation End ProductsIBA 08/2014 - 12/2013
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2014 - 10/2013
1	sugiolIBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2022
1	InterleukinsIBA 10/2021
1	Caspase 3 (Caspase-3)IBA 05/2021
1	gigantolIBA 05/2021
1	Oxidoreductases (Dehydrogenase)IBA 03/2021
1	HesperidinIBA 03/2021
1	Metal-Organic FrameworksIBA 01/2021
1	luteolin-7-glucosideIBA 01/2021
1	AcetylcholinesteraseIBA 01/2021
1	sesamolIBA 01/2021
1	miltefosine (Impavido)IBA 01/2021
1	Glycogen Synthase (Synthase I)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 08/2020
1	ResveratrolIBA 01/2020
1	CurcuminIBA 01/2020
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2020
1	MicronutrientsIBA 05/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019
1	fasudil (AT 877)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Fibrinogen (Factor I)FDA Link 01/2019
1	Polo-Like Kinase 1IBA 01/2019
1	Y 27632IBA 01/2019

Therapy/Procedure

11	Therapeutics 11/2022 - 01/2012
7	Drug Therapy (Chemotherapy) 11/2022 - 01/2012
3	Immunotherapy 11/2022 - 01/2015
3	Radiotherapy 11/2022 - 05/2019
2	Chemoprevention 01/2021 - 01/2013
1	Complementary Therapies (Alternative Medicine) 05/2019